Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Experimental Designs01:16

Experimental Designs

11.3K
An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
11.3K
Teratogenicity01:07

Teratogenicity

4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

383
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
383
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective economic evaluation ancillary to a trial of higher versus lower hemoglobin transfusion thresholds for preterm infants.

Neonatology·2026
Same author

Correlation of Oxygen Saturation Index with Oxygenation Index in Congenital Diaphragmatic Hernia: in A Secondary Analysis of a Randomized Clinical Trial.

The Journal of pediatrics·2026
Same author

Budesonide and Surfactant Therapy Versus Surfactant Alone on Incidence of Lung Disease in Preterm Infants (BEST Lung): Study Protocol for a Systematic Review and Individual Participant Data Meta-Analysis With Nested Prospective Meta-Analysis.

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

Parent-reported quality of life at school age among children born extremely preterm is associated with non-medical determinants of health and developmental outcomes.

Early human development·2026
Same author

Symptom-Based Dosing for Neonatal Opioid Withdrawal: The OPTimize NOW Randomized Clinical Trial.

JAMA·2026
Same author

Temporal trends in outcomes for infants with neonatal opioid withdrawal managed with the Finnegan scoring tool: Insights from the INFORM NOW Study.

Journal of perinatology : official journal of the California Perinatal Association·2026

Related Experiment Video

Updated: May 2, 2026

Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

23.4K

Extended Caffeine for Apnea in Moderately Preterm Infants: The MoCHA Randomized Clinical Trial.

Waldemar A Carlo1, Eric C Eichenwald2, Benjamin A Carper3

  • 1Department of Pediatrics, Division of Neonatology, University of Alabama at Birmingham.

JAMA
|April 28, 2025
PubMed
Summary

Extending caffeine treatment for moderately preterm infants did not shorten hospital stays. This study found no significant difference in hospitalization duration or physiological maturity between caffeine and placebo groups.

More Related Videos

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

19.5K
Manipulation of Gene Function in Mexican Cavefish
07:01

Manipulation of Gene Function in Mexican Cavefish

Published on: April 22, 2019

9.0K

Related Experiment Videos

Last Updated: May 2, 2026

Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

23.4K
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

19.5K
Manipulation of Gene Function in Mexican Cavefish
07:01

Manipulation of Gene Function in Mexican Cavefish

Published on: April 22, 2019

9.0K

Area of Science:

  • Neonatology
  • Pediatric Pharmacology
  • Clinical Trials

Background:

  • Hospitalization for moderately preterm infants can be prolonged due to apnea of prematurity after caffeine discontinuation.
  • Optimizing treatment duration is crucial for reducing healthcare costs and improving infant outcomes.

Purpose of the Study:

  • To investigate whether extending caffeine citrate treatment reduces hospitalization duration in moderately preterm infants.
  • To assess the impact of extended caffeine on physiological maturity and other clinical outcomes.

Main Methods:

  • A randomized clinical trial involving 827 infants born at 29-33 weeks' gestation across 29 US hospitals.
  • Infants received either oral caffeine citrate or placebo until 28 days post-discharge, with follow-up completed in March 2023.
  • Primary outcome was days to discharge; secondary outcomes included physiological maturity, readmissions, and adverse events.

Main Results:

  • Continuation of caffeine treatment did not significantly shorten the duration of hospitalization compared to placebo (18.0 vs 16.5 days).
  • No significant differences were observed in days to physiological maturity, full oral feeding, readmissions, or sick visits.
  • Infants on caffeine achieved apnea-free status sooner, but this did not translate to shorter overall hospital stays.

Conclusions:

  • Extending caffeine treatment beyond standard protocols does not appear to reduce hospitalization duration in moderately preterm infants.
  • The findings suggest current caffeine discontinuation strategies are appropriate for this population.
  • Further research may explore alternative interventions for managing apnea of prematurity and optimizing discharge timing.